Cosmetics

Cosmetics, as regulated by the U.S. Food and Drug Administration (FDA), encompass a wide range of products intended for beautifying, promoting attractiveness, or altering the appearance without affecting the body’s structure or functions. This includes items like skin moisturizers, perfumes, lipsticks, fingernail polishes, eye and facial makeup, cleansing shampoos, hair colors, and deodorants.

Unlike drugs or medical devices, cosmetics do not require FDA premarket approval, except for color additives. However, they must adhere to the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA), which mandate safety, proper labeling, and prohibit the sale of adulterated or misbranded products. The Modernization of Cosmetics Regulation Act (MoCRA), signed into law on December 29, 2022, introduces significant new regulatory requirements intended to enhance the safety, traceability, and quality of cosmetics and skincare products sold in the U.S.

Under MoCRA, cosmetic companies will be required, for the first time, to register their facilities and list their products with the FDA beginning on July 1, 2024. Additional requirements include record-keeping, adverse event reporting, product safety substantiation, and updated labeling requirements. The FDA now has the authority to order mandatory recalls of cosmetics and will publish final regulations regarding good manufacturing practices (GMP) for cosmetics by the end of 2025.

Manufacturers bear the responsibility for ensuring the safety of their cosmetics, and while specific tests are not mandated, they must ensure their products are safe under customary conditions of use. The regulatory landscape for cosmetics emphasizes compliance and safety without the stringent premarket approval processes required for other FDA-regulated products.

At Asebey Life Science Law, we provide expert legal guidance to help clients navigate the complexities of cosmetic regulation. We assist companies in identifying and meeting their MoCRA compliance requirements, ensuring that their products meet all federal standards for safety and labeling, thereby supporting market success and consumer trust.

Services Provided

  • MoCRA regulatory compliance
  • Cosmetic label compliance review
  • OTC listing of cosmetics containing SPFs
  • Removal from FDA Import Alert
  • Respond to FDA Warning Letters and Form 483s
  • Regulatory opinion on whether a product is a cosmetic or a drug
  • California Prop 65 enforcement defense
  • Import / CBP compliance for importation of cosmetics
  • Management of CBP detentions and refusals
  • Cosmetics GMP compliance

Representative Matters

  • Successfully defended a cosmetics client against allegations of violating Prop 65 for titanium dioxide use
  • Assisted a large Latin American cosmetic company with FDA compliance and listed over 200 products as OTC cosmetics
  • Retained by the United Nations Industrial Development Program (UNIDO) to train Latin American cosmetics and OTC product manufacturers on FDA regulatory compliance
  • Designed and taught FDA cosmetics regulation seminars to cosmetics manufacturers in Bogotá, Cali, and MedellĂ­n at the request of the Colombian Government
  • Advised a client on implementing a MoCRA compliance program
  • Managed a product recall for a cosmetics client
  • Provided regulatory opinions on certain natural products and their bioactivity in cosmetic products
  • Responded to FDA Warning Letters on behalf of cosmetics clients

Tell us more about your regulatory needs so we can help you succeed.

Request a consultation